Oklo Q2 2026: net loss widens 97% to $48.5M on non-operating factors as operating loss deepens 161%

Filed August 7, 2026 · Period ending June 30, 2026 · Compared to 10-Q Aug 11, 2025 · ~2 min read

Key Changes

• high

  Net loss widened 97% to $48.5M (diluted EPS -$0.28, -56%) while operating loss deepened 161% to $73.2M — the net-income change did NOT come from operations. Below-the-line items improved $21.3M YoY (non-operating/other +$17.7M, income tax +$3.6M), partially offsetting the operational deterioration.

  MD&A: Operating Results verify on EDGAR →
• high

  Acquired ARMEC and Creative Engineers in June 2026 for $33M total, adding precision manufacturing, mechanical engineering, and chemical process expertise for sodium/alkali-metal systems. The acquisitions generated the company's first revenue: $1.2M in Q2 2026 from engineering services to government and commercial customers.

  MD&A: Acquisitions & Revenue verify on EDGAR →
• high

  Groves Isotope Test Reactor achieved first criticality on August 5, 2026 — the first reactor under the DOE Reactor Pilot Program to reach criticality on private land. The low-power test reactor demonstrates end-to-end execution capability (design, build, operate) using commercially sourced components and private capital.

  MD&A: Groves Reactor verify on EDGAR →